Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2015 - 2026)

Perspective Therapeutics (CATX) has 10 years of Change in Acquisitions & Divestments data on file, last reported at $47.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 119.5% year-over-year to $47.6 million; the trailing twelve-month figure through Mar 2026 stood at $199.9 million (up 99.02% YoY), and the FY2025 full-year result was $174.0 million, up 120.95% from the prior year.
• Change in Acquisitions & Divestments declined to $47.6 million in Q1 2026, from $174.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $174.0 million in Q4 2025 to a low of -$21.7 million in Q2 2025.
• A 5-year average of $47.9 million and a median of $22.8 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 120.95% in 2025 and surged 119.5% in 2026, its largest moves.
• Tracing CATX's Change in Acquisitions & Divestments over 5 years: stood at $12.5 million in 2022, then soared by 81.56% to $22.8 million in 2023, then surged by 245.85% to $78.7 million in 2024, then jumped by 120.95% to $174.0 million in 2025, then sank by 72.61% to $47.6 million in 2026.
• Business Quant data shows CATX's Change in Acquisitions & Divestments at $47.6 million in Q1 2026, $174.0 million in Q4 2025, and -$21.7 million in Q2 2025.